Скачать или смотреть Transparent future: ORCiD, CRediT and Convey

Tim Koder, Communications Director, Oxford PharmaGenesis, reviews three solutions that aim to increase transparency, reduce administrative burden and ensure more accountability in publishing.

Recorded 17 October 2018 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

ABSTRACT:

Open Pharma aims to improve the medical publications model by connecting pharma with innovations in publishing. We are coordinating a group of forward-thinking pharma clients, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies to identify the changes that are needed and how they might be achieved. We are engaged with the open science movement and aim to advance in our world of medical publishing topics such as open access, preprints, author identification and disclosure, and data sharing. Open Pharma is a non-profit-seeking project at Oxford PharmaGenesis, which is funded by members and supporters.

In this talk, we discuss three innovations in publishing that aim to increase transparency and efficiency in the authorship disclosure process: ORCID, CRediT and Convey. We provide an overview of these innovations, highlighting their benefits and potential future uses in medical publishing.

Written by Tim Koder, Communications Director, Oxford PharmaGenesis

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Tim’s Linkedin page is at   / tim-koder-8611883  

More about Oxford PharmaGenesis can be found at http://www.pharmagenesis.com/

More about Open Pharma can be found at https://openpharma.blog

Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free recordings, like this one, for a global pharmaceutical industry audience at NetworkPharma.tv and we’d welcome your suggestions for new topics and speakers.

For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like.